Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial of BMS-986020, a Lysophosphatidic Acid Receptor Antagonist for the Treatment of Idiopathic Pulmonary Fibrosis

Abstract

ClinicalTrials.gov; No.: NCT01766817; URL: www.clinicaltrials.gov.